192 related articles for article (PubMed ID: 9309767)
1. Validating targets for antiparasite chemotherapy.
Wang CC
Parasitology; 1997; 114 Suppl():S31-44. PubMed ID: 9309767
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Parasite Cathepsin D-Like Peptidases and Their Relevance as Therapeutic Targets.
Sojka D; Hartmann D; Bartošová-Sojková P; Dvořák J
Trends Parasitol; 2016 Sep; 32(9):708-723. PubMed ID: 27344362
[TBL] [Abstract][Full Text] [Related]
4. The current status of antiparasite chemotherapy.
Croft SL
Parasitology; 1997; 114 Suppl():S3-15. PubMed ID: 9309765
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide signalling: a repository of targets for novel endectocides?
Mousley A; Marks NJ; Maule AG
Trends Parasitol; 2004 Oct; 20(10):482-7. PubMed ID: 15363442
[TBL] [Abstract][Full Text] [Related]
6. Genomic filtering: an approach to discovering novel antiparasitics.
McCarter JP
Trends Parasitol; 2004 Oct; 20(10):462-8. PubMed ID: 15363439
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor.
Diaz CA; Allocco J; Powles MA; Yeung L; Donald RG; Anderson JW; Liberator PA
Mol Biochem Parasitol; 2006 Mar; 146(1):78-88. PubMed ID: 16325279
[TBL] [Abstract][Full Text] [Related]
8. Unified QSAR & network-based computational chemistry approach to antimicrobials. II. Multiple distance and triadic census analysis of antiparasitic drugs complex networks.
Prado-Prado FJ; Ubeira FM; Borges F; González-Díaz H
J Comput Chem; 2010 Jan; 31(1):164-73. PubMed ID: 19421992
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Inhibitors as Antiparasitic Drugs: Pharmacological, Biochemical and Molecular Perspectives.
Mukherjee S; Mukherjee N; Gayen P; Roy P; Babu SP
Curr Drug Metab; 2016; 17(10):937-970. PubMed ID: 27719626
[TBL] [Abstract][Full Text] [Related]
10. Apicomplexa, trypanosoma and parasitic nematode protein kinases as antiparasitic therapeutic targets.
Liotta F; Siekierka JJ
Curr Opin Investig Drugs; 2010 Feb; 11(2):147-56. PubMed ID: 20112164
[TBL] [Abstract][Full Text] [Related]
11. Parasite enzymes as potential targets for antiparasitic chemotherapy.
Wang CC
J Med Chem; 1984 Jan; 27(1):1-9. PubMed ID: 6317859
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and metabolic peculiarities of some parasites availing as targets for therapy.
Frayha GJ; Gobert JG; Savel J
J Med Liban; 2001; 49(4):210-27. PubMed ID: 12412970
[TBL] [Abstract][Full Text] [Related]
13. Control of parasitic disease using vaccines: an answer to drug resistance?
Vercruysse J; Schetters TP; Knox DP; Willadsen P; Claerebout E
Rev Sci Tech; 2007 Apr; 26(1):105-15. PubMed ID: 17633296
[TBL] [Abstract][Full Text] [Related]
14. Rational drug design using trypanothione reductase as a target for anti-trypanosomal and anti-leishmanial drug leads.
Austin SE; Khan MO; Douglas KT
Drug Des Discov; 1999 Jul; 16(1):5-23. PubMed ID: 10466053
[TBL] [Abstract][Full Text] [Related]
15. Polyamine transport in parasites: a potential target for new antiparasitic drug development.
Reguera RM; Tekwani BL; Balaña-Fouce R
Comp Biochem Physiol C Toxicol Pharmacol; 2005 Feb; 140(2):151-64. PubMed ID: 15907761
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
17. The changing landscape of antiparasitic drug discovery for veterinary medicine.
Geary TG; Conder GA; Bishop B
Trends Parasitol; 2004 Oct; 20(10):449-55. PubMed ID: 15363437
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria as a promising antiparasitic target.
Monzote L; Gille L
Curr Clin Pharmacol; 2010 Feb; 5(1):55-60. PubMed ID: 20236083
[TBL] [Abstract][Full Text] [Related]
19. [Type I DNA topoisomerase from protozoan pathogens as a potential target for anti-tumoral drugs].
Reguera RM; Pérez-Pertejo Y; Redondo CM; Díaz-González R; Balaña-Fouce R
Medicina (B Aires); 2007; 67(6 Pt 2):747-57. PubMed ID: 18422072
[TBL] [Abstract][Full Text] [Related]
20. Sirtuins as emerging anti-parasitic targets.
Zheng W
Eur J Med Chem; 2013 Jan; 59():132-40. PubMed ID: 23220641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
